CIK 0001727196 · Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823750435
- Phone
- 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-23 | Burow Kristina Director | Option exercise · Stock Option (Right to Buy) | −28,000 | 0 | ||
| 2026-04-23 | Burow Kristina Director | Option exercise · Stock Option (Right to Buy) | −36,000 | 0 | ||
| 2026-04-23 | Burow Kristina Director | Option exercise · Stock Option (Right to Buy) | −18,000 | 0 | ||
| 2026-04-16 | Woods Keith Chief Operating Officer | Sale | −10,220 | $49.57 | $507K | 620,055 |
| 2026-04-16 | Vaishnaw Akshay President of R&D | Sale | −12,246 | $49.57 | $607K | 630,542 |
| 2026-04-16 | Sinha Vikas Chief Financial Officer | Sale | −10,410 | $49.57 | $516K | 619,856 |
| 2026-04-16 | Hallal David Chief Executive Officer | Sale | −30,615 | $49.57 | $1.5M | 1,639,034 |
| 2026-02-23 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −7,427 | $46.94 | $349K | 99,502 |
| 2026-02-23 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −857 | $47.86 | $41K | 98,645 |
| 2026-02-23 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −200 | $48.48 | $10K | 98,445 |
| 2026-02-17 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | −7,989 | $46.53 | $372K | 106,929 |
| 2026-02-17 | Parlavecchio Caryn CHRO | Sale | −9,035 | $46.53 | $420K | 169,087 |
| 2026-02-17 | Ho Junlin GENERAL COUNSEL | Sale | −9,580 | $46.53 | $446K | 241,545 |
| 2026-02-17 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale | −4,157 | $46.53 | $193K | 126,012 |
| 2026-02-09 | Vaishnaw Akshay President of R&D | Grant or award | +47,021 | 642,788 | ||
| 2026-02-09 | Sinha Vikas Chief Financial Officer | Grant or award | +47,021 | 630,266 | ||
| 2026-02-09 | Qatanani Mo Chief Scientific Officer | Grant or award | +29,258 | 114,918 | ||
| 2026-02-09 | Parlavecchio Caryn Chief Human Resources Officer | Grant or award | +29,258 | 178,122 | ||
| 2026-02-09 | Marantz Jing L. Chief Medical Officer | Grant or award | +34,482 | 130,169 | ||
| 2026-02-09 | Ho Junlin General Counsel | Grant or award | +36,572 | 251,125 |
Page 3 of 12 · 227 trades